Low-dose urinary human chorionic gonadotropin is effective for oocyte maturation in In vitro fertilization/intracytoplasmic sperm injection cycles independent of body mass index

Luis R. Hoyos, Sana Khan, Jing Dai, Manvinder Singh, Michael Peter Diamond, Elizabeth E. Puscheck, Awoniyi O. Awonuga

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Currently, there is no agreement on the optimal urinary derived human chorionic gonadotropin (u-hCG) dose requirement for initiating final oocyte maturation prior to oocyte collection in in vitro fertilization (IVF), but doses that range from 250015000 IU have been used. We intended to determine whether low dose u-hCG was effective for oocyte maturation in IVF/intracytoplasmic sperm injection (ICSI) cycles independent ofbody mass index (BMI). Materials and Methods: We retrospectively evaluated a cohort of 295 women who underwent their first IVF/ICSI cycles between January 2003 and December 2010 at the Division of Reproductive Endocrinology and Infertility, Wayne State University, Detroit, MI, USA. Treatment cycles were divided into 3 groups based on BMI (kg/ m2): <25 (n=136), 25- <30 (n=84), and ≥30 (n=75) women. Patients received 5000, 10000 or 15000 IU u-hCG for final maturation prior to oocyte collection. The primary outcome was clinical pregnancy rates (CPRs) and secondary outcome was live birth rates (LBRs). Results: Only maternal age negatively impacted (P<0.001) CPR [odds ratio (OR=0.85, confidence interval (Cl: 0.79-0.91)] and LBR (OR=0.84, Cl: 0.78-0.90). Conclusion: Administration of lower dose u-hCG was effective for oocyte maturation in IVF and did not affect the CPRs and LBRs irrespective of BMI. Women’s BMI need not be taken into consideration in choosing the appropriate dose of u-hCG for final oocyte maturation prior to oocyte collection in IVF. Only maternal age at the time of IVF negatively influenced CPRs and LBRs in this study.

Original languageEnglish (US)
Pages (from-to)7-14
Number of pages8
JournalInternational Journal of Fertility and Sterility
Volume11
Issue number1
StatePublished - Jan 1 2017

Fingerprint

Intracytoplasmic Sperm Injections
Chorionic Gonadotropin
Fertilization in Vitro
Oocytes
Body Mass Index
Birth Rate
Pregnancy Rate
Oocyte Retrieval
Maternal Age
Live Birth
Endocrinology
Infertility
Odds Ratio
Confidence Intervals

Keywords

  • Body mass index
  • In vitro fertilization
  • Live birth rate
  • Pregnancy rate
  • Urinary human chorionic gonadotropin

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Low-dose urinary human chorionic gonadotropin is effective for oocyte maturation in In vitro fertilization/intracytoplasmic sperm injection cycles independent of body mass index. / Hoyos, Luis R.; Khan, Sana; Dai, Jing; Singh, Manvinder; Diamond, Michael Peter; Puscheck, Elizabeth E.; Awonuga, Awoniyi O.

In: International Journal of Fertility and Sterility, Vol. 11, No. 1, 01.01.2017, p. 7-14.

Research output: Contribution to journalArticle

@article{d0ea3e6b080d4d5f80c8895bf20a69ab,
title = "Low-dose urinary human chorionic gonadotropin is effective for oocyte maturation in In vitro fertilization/intracytoplasmic sperm injection cycles independent of body mass index",
abstract = "Background: Currently, there is no agreement on the optimal urinary derived human chorionic gonadotropin (u-hCG) dose requirement for initiating final oocyte maturation prior to oocyte collection in in vitro fertilization (IVF), but doses that range from 250015000 IU have been used. We intended to determine whether low dose u-hCG was effective for oocyte maturation in IVF/intracytoplasmic sperm injection (ICSI) cycles independent ofbody mass index (BMI). Materials and Methods: We retrospectively evaluated a cohort of 295 women who underwent their first IVF/ICSI cycles between January 2003 and December 2010 at the Division of Reproductive Endocrinology and Infertility, Wayne State University, Detroit, MI, USA. Treatment cycles were divided into 3 groups based on BMI (kg/ m2): <25 (n=136), 25- <30 (n=84), and ≥30 (n=75) women. Patients received 5000, 10000 or 15000 IU u-hCG for final maturation prior to oocyte collection. The primary outcome was clinical pregnancy rates (CPRs) and secondary outcome was live birth rates (LBRs). Results: Only maternal age negatively impacted (P<0.001) CPR [odds ratio (OR=0.85, confidence interval (Cl: 0.79-0.91)] and LBR (OR=0.84, Cl: 0.78-0.90). Conclusion: Administration of lower dose u-hCG was effective for oocyte maturation in IVF and did not affect the CPRs and LBRs irrespective of BMI. Women’s BMI need not be taken into consideration in choosing the appropriate dose of u-hCG for final oocyte maturation prior to oocyte collection in IVF. Only maternal age at the time of IVF negatively influenced CPRs and LBRs in this study.",
keywords = "Body mass index, In vitro fertilization, Live birth rate, Pregnancy rate, Urinary human chorionic gonadotropin",
author = "Hoyos, {Luis R.} and Sana Khan and Jing Dai and Manvinder Singh and Diamond, {Michael Peter} and Puscheck, {Elizabeth E.} and Awonuga, {Awoniyi O.}",
year = "2017",
month = "1",
day = "1",
language = "English (US)",
volume = "11",
pages = "7--14",
journal = "International Journal of Fertility and Sterility",
issn = "2008-076X",
publisher = "Royan Institute",
number = "1",

}

TY - JOUR

T1 - Low-dose urinary human chorionic gonadotropin is effective for oocyte maturation in In vitro fertilization/intracytoplasmic sperm injection cycles independent of body mass index

AU - Hoyos, Luis R.

AU - Khan, Sana

AU - Dai, Jing

AU - Singh, Manvinder

AU - Diamond, Michael Peter

AU - Puscheck, Elizabeth E.

AU - Awonuga, Awoniyi O.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Background: Currently, there is no agreement on the optimal urinary derived human chorionic gonadotropin (u-hCG) dose requirement for initiating final oocyte maturation prior to oocyte collection in in vitro fertilization (IVF), but doses that range from 250015000 IU have been used. We intended to determine whether low dose u-hCG was effective for oocyte maturation in IVF/intracytoplasmic sperm injection (ICSI) cycles independent ofbody mass index (BMI). Materials and Methods: We retrospectively evaluated a cohort of 295 women who underwent their first IVF/ICSI cycles between January 2003 and December 2010 at the Division of Reproductive Endocrinology and Infertility, Wayne State University, Detroit, MI, USA. Treatment cycles were divided into 3 groups based on BMI (kg/ m2): <25 (n=136), 25- <30 (n=84), and ≥30 (n=75) women. Patients received 5000, 10000 or 15000 IU u-hCG for final maturation prior to oocyte collection. The primary outcome was clinical pregnancy rates (CPRs) and secondary outcome was live birth rates (LBRs). Results: Only maternal age negatively impacted (P<0.001) CPR [odds ratio (OR=0.85, confidence interval (Cl: 0.79-0.91)] and LBR (OR=0.84, Cl: 0.78-0.90). Conclusion: Administration of lower dose u-hCG was effective for oocyte maturation in IVF and did not affect the CPRs and LBRs irrespective of BMI. Women’s BMI need not be taken into consideration in choosing the appropriate dose of u-hCG for final oocyte maturation prior to oocyte collection in IVF. Only maternal age at the time of IVF negatively influenced CPRs and LBRs in this study.

AB - Background: Currently, there is no agreement on the optimal urinary derived human chorionic gonadotropin (u-hCG) dose requirement for initiating final oocyte maturation prior to oocyte collection in in vitro fertilization (IVF), but doses that range from 250015000 IU have been used. We intended to determine whether low dose u-hCG was effective for oocyte maturation in IVF/intracytoplasmic sperm injection (ICSI) cycles independent ofbody mass index (BMI). Materials and Methods: We retrospectively evaluated a cohort of 295 women who underwent their first IVF/ICSI cycles between January 2003 and December 2010 at the Division of Reproductive Endocrinology and Infertility, Wayne State University, Detroit, MI, USA. Treatment cycles were divided into 3 groups based on BMI (kg/ m2): <25 (n=136), 25- <30 (n=84), and ≥30 (n=75) women. Patients received 5000, 10000 or 15000 IU u-hCG for final maturation prior to oocyte collection. The primary outcome was clinical pregnancy rates (CPRs) and secondary outcome was live birth rates (LBRs). Results: Only maternal age negatively impacted (P<0.001) CPR [odds ratio (OR=0.85, confidence interval (Cl: 0.79-0.91)] and LBR (OR=0.84, Cl: 0.78-0.90). Conclusion: Administration of lower dose u-hCG was effective for oocyte maturation in IVF and did not affect the CPRs and LBRs irrespective of BMI. Women’s BMI need not be taken into consideration in choosing the appropriate dose of u-hCG for final oocyte maturation prior to oocyte collection in IVF. Only maternal age at the time of IVF negatively influenced CPRs and LBRs in this study.

KW - Body mass index

KW - In vitro fertilization

KW - Live birth rate

KW - Pregnancy rate

KW - Urinary human chorionic gonadotropin

UR - http://www.scopus.com/inward/record.url?scp=85008151735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008151735&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 7

EP - 14

JO - International Journal of Fertility and Sterility

JF - International Journal of Fertility and Sterility

SN - 2008-076X

IS - 1

ER -